Pneumothorax, pneumomediastinum, and subcutaneous emphysema in hospitalized COVID-19 patients: incidence, clinical characteristics, and outcomes
CONCLUSION: Although the occurrence of PTX/PNM/SCE in hospitalized COVID-19 patients was rare, it was associated with worse outcomes. Corticosteroids may contribute to the pathogenesis of these complications; however, further studies are needed to investigate this relationship in more detail.PMID:37675598 | DOI:10.1080/17476348.2023.2254689
Source: Expert Review of Respiratory Medicine - Category: Respiratory Medicine Authors: Aleksandra Murawska Baptista Jorge Sinclair De Fr ías Trisha Singh Ananya Vasudhar Jacob Guzzino Waheed Khalili Aysun Tekin Vikas Bansal Rahul Kashyap William J Joyce Patricia A Lewis Devang Sanghavi Tatjana Gavrancic Pablo Moreno Franco Source Type: research
More News: Chronic Obstructive Pulmonary | Corticosteroid Therapy | COVID-19 | Emphysema | Pneumothorax | Respiratory Medicine | Study